“‘Usually, you’d be able to detect it pretty close to when symptoms appear, for most viruses,'” said David Deetz, CEO of St. Paul’s Ativa Medical, which is developing a point-of-care test for COVID-19 that is still months from commercial release. “‘That’s why no one can contain this thing. … You become contagious early, and can’t detect it until late. That’s the main problem.'”
“More than a dozen companies including Ativa are working on point-of-care systems that could offer rapid early detection of COVID-19, said Divyaa Ravishankar, a global product marketing manager with Ohio-based medical research organization NAMSA.”
MAA COVID-19 INFORMATION DISCLAIMER:
The Medical Alley Association is providing COVID-19 related information, including the “COVID-19 Resource Connect” feature on its website and summaries of laws, executive orders, and government programs that may be of interest to members, as a public service. The Medical Alley Association makes no representations, guarantees, or warranties as to the accuracy, completeness, currency, or suitability of the COVID-19 related information provided by the Medical Alley Association on its website, in newsletters, or in any other communications. The Medical Alley Association specifically disclaims any and all liability for any claims or damages that may result from providing COVID-19 related information online or in other communications or linking to third party websites or other sources of information. The Medical Alley Association makes no effort to independently verify, and does not exert editorial control over, information provided by third parties.
The Medical Alley Association does not endorse any of the products, vendors, consultants, or documentation referenced in, or connected to parties through, the COVID-19 Resource Connect feature or via this email or other communications.